{"name":"Elixir Pharmaceuticals","slug":"elixir-pharmaceuticals","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxNenpTSVo3cThTdm1VTkk0YUNpYUR0M0FieTVWblhJczluMXdobUdNRnltZHJCeGJCdjBlTU1tT2hNWnB0WGhWT01sZVFXS3ZKV1lRNk1kYVNCQ3lNWjEtVkRUeTVtUmhwSWd5dS10YjB3QkJFTW1ES09vOXVUNmljUm9ab1ZSZ0RvTTNlbnE4WlZFa3RtdWhlV1dMYjA4YWFsN0JSU0xPM0NrMnE4S21lNHlzS3ppbmtrWDRaM214RmNVbDdEbjh5UmZSSFZXbkJWTlh30gHYAUFVX3lxTE9wME1tTWktU2RMWVNXOTRaQURGSW1PN1ZEaC02TGJKY2RlTi03cDFzaW5zQkQ3VGxfd0t1Z21iSDQ5OGlsRGZ0SHZlUHlneVloNHBQWmJjS1gtdk00OUQwODNqTS00QkVtbldBekdwdHp4T3l0REFyenl1aXhLVVdLblFBZzhhMmdiTDF6VWR0d2JRMUlGdHdjbGczUlYtTTQxSDNQY0U5eW04TkNqeVA4aC1HN0hzVXZxUmZPMGhsdVViaFNLU0o3aGZKS3ZiWFlJR3VQQVdQaQ?oc=5","date":"2026-02-26","type":"pipeline","source":"CNBC TV18","summary":"Dipan Mehta prefers pharma, specialty chemicals; stays cautious on IT, exits Info Edge - CNBC TV18","headline":"Dipan Mehta prefers pharma, specialty chemicals; stays cautious on IT, exits Info Edge - CNBC TV18","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE1Ta2ZqSWZFelJDQ0dmb256eC16RXlQSTh4YmhmSExWczhaNjhUTXJjYVl1azcwbEZibF9wb2NSV0xJVkZWRmY0MWh4UjlWSEdVLUlUdkRIX2FDR0VJbldYUXEzR1RwSERSWXRsYkZOeEFocmxmQ0ZHUWFBM3ZqZw?oc=5","date":"2025-11-04","type":"pipeline","source":"The New York Times","summary":"French Pharmacy Skin Care That Actually Deserves the Hype - The New York Times","headline":"French Pharmacy Skin Care That Actually Deserves the Hype","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNMUJSeHVIWU1UWTBhek9qcnBzYmhPdGFoMDNxNFl1aENGZGZhMmdWR0hEX05CT0xHYkpDdERGX2pqYWdreVJfeWZhcFpMbmtBQlFhRV95ZmM5aWx5V1h4S05TMS1XNkdIMFowYUNfT05qWUF6MWhuSExlQktWZmRpbVBZR0p2Y0hyeDZZMFpfTHR6VzdXNU9NemtQMEtWTTZ3ZVJIbQ?oc=5","date":"2025-09-25","type":"pipeline","source":"statnews.com","summary":"From an elixir for ‘little hotheads’ to deadly overdoses, how Tylenol became a medicinal scapegoat - statnews.com","headline":"From an elixir for ‘little hotheads’ to deadly overdoses, how Tylenol became a medicinal scapegoat","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxNazE0Nmd4V1BtUmczUldPc3lHUEtlc1VDRVlldHVQMFR6LWM5Z1k4d29mSENYLWduN2FhblpSUXE5dGw4MDBNanJTOHJlLXB3dG1iYVpFMjNndVZrZGkwb1NDeEdieHZLRk94ZnFueF80THFYTEpyWWoyaGNDcWh6NW9sUjk5bWpyNENraU9nRlNEN2piSWFyVWlTQmxRNjA?oc=5","date":"2025-07-24","type":"pipeline","source":"Spotlight PA","summary":"Rite Aid closures add to the strain as Pennsylvania loses hundreds of pharmacies - Spotlight PA","headline":"Rite Aid closures add to the strain as Pennsylvania loses hundreds of pharmacies","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-07-11","type":"deal","source":"outlookbusiness.com","summary":"How Glenmark’s AbbVie Deal is a Masterclass in Indian Pharma's R&D Ambitions - outlookbusiness.com","headline":"How Glenmark’s AbbVie Deal is a Masterclass in Indian Pharma's R&D Ambitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQa3pLSmh3eU05bUhlNWlLdjdBSkZJdmpOQUJuRTJpNmxaYUlGWFdVMzBmSnJWbUdYdGtGbmlMTnY2dWdaZUx6QjVlTHBSX3hlVEMyZ0t1RlVBZ216T0JfemItZ2pUdXptMXgzZmRRNE5lSVZQakxGNTVTT1NqOVQ3VmpzR0pyR2ItSW00bnVURnRWNWg4YlkzVmlNcnEzQ0RJRlZjNV9qbVRmdks0UzNqUEdHbldXclE?oc=5","date":"2025-05-06","type":"pipeline","source":"Democrat and Chronicle","summary":"Major pharmacy chain going out of business - Democrat and Chronicle","headline":"Major pharmacy chain going out of business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxPd2tBUVg3bU85ZHlKTGxDeWxxUnNyZTdsSGVJemtkZmhKZHo1NENQUkdocmdPaG5EdEwwN0pNRlNkR0w5WjNkdmhNdHBKdWlwVnJQRVdNeDdlZ0JmNGp2RmhBY3QtVVctTllaUTNUNTRneGNGVjF3bUVnYU5GRnl4OTJmQjU?oc=5","date":"2024-04-09","type":"pipeline","source":"drugchannels.net","summary":"The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead - drugchannels.net","headline":"The Top Pharmacy Benefit Managers of 2023: Market Share and Trends for the Biggest Companies—And What’s Ahead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQZms3N1YtTnVsYWVKRGsxSjdSdDlrV0ZveUNabUg1MnAtMVlrT1ZNUXZKRk8zN3JvSU02VnBXMm96TmhfNFE5ZE9aWGhpMTRsWm1QNU5VQnVhQUhrUy1MdVZPbHFoM3QxTTI3WVN0WDhSbzVRY0R2a1N5alNGTi1lWWVnRl91TTB6X0p2RTFHNl85TTRabnc?oc=5","date":"2024-02-01","type":"pipeline","source":"Managed Healthcare Executive","summary":"Rite Aid Completes Sale of Elixir Solutions - Managed Healthcare Executive","headline":"Rite Aid Completes Sale of Elixir Solutions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNU2hHUU9KSWhfQTROY1VEc3FlS0lGbk5wZkc5YTA1aFVsNjRmdTFuVnZEbHNNUml5dUxzbnhfNm9JVVIyMGhldktNTDg0cWNvcUZZWkVraWhOVWJEOXpUenJMVDAzOUl3eDVhTWc3V1JaT1RfVVNmYkwzSFliT3NRaVl0ak8tdzhlVXphdWdFOUFKTFlaUzRGS1dvWXhBWkVMN21qNw?oc=5","date":"2024-01-09","type":"regulatory","source":"reuters.com","summary":"Rite Aid gets court approval for $575 million Elixir sale - reuters.com","headline":"Rite Aid gets court approval for $575 million Elixir sale","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPaTI3RW5TYnNtdUlubkQ3Q1JaMW5zRC10Rk0xbkk3N01KSkVpcE10YjJGajhmQlBpRDNfS052RFNOQ0U2cUZfV3g2NmlFY2tzSlpYbWVVaDJaREczZUN6bjdWdXFtMWlLakktZDlLb3JGN3Y5NEhNeVdsTTNIaWNCbVpWQTk0NDlkbk52aDlXUng?oc=5","date":"2023-11-02","type":"deal","source":"pehub.com","summary":"Bankrupt Rite Aid’s Elixir business ripe for mid-market PE buyout - pehub.com","headline":"Bankrupt Rite Aid’s Elixir business ripe for mid-market PE buyout","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2wFBVV95cUxNd1dIdWcwNVF2T1k3ZGpxUkpseERHcWhnaGtkUHRoSFRRT1ZGbXNoSlluS09NOUlNWmNsWXhsWmNRTW8tSjJwN2dIVWk1bHp3Z3Z3TmFpTlJjS2lOWEMweXdmdTJ6WXhMdUstbzZ6TmF5by1PMWpRQlNKRG5HRUxYMmZjTU9HTUNDbEFScGFfMVA1NVhnU2NIMGhldkhaVlgtMzNLX3Y4c3MwLW1DLTNqcjRnVDlfa0Y5eE1uQzBWR0tIcDdSLU56YURuZVBMTGlBUW0tdV9xSUFkb2c?oc=5","date":"2023-05-23","type":"pipeline","source":"Business Wire","summary":"Elixir announces the next wave of innovation for pharmacy benefits technology platform - Business Wire","headline":"Elixir announces the next wave of innovation for pharmacy benefits technology platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxONHppbzBaLWpaM2ExWU9ZSVdPaTlLY0JhbFl3MFY0SE1UdW5xVUJoT0toYnc0UlJuTlZSY1ZSaWtnaXJPZHFGWnA2Q3FBS0g4OUczVlNEdWhSdm5Ic2dDRHVncDBjYUNKenBIT2VqOXE2MDViZEhCR3FCSnZyN1pObUlCamZwYUlBNjF4YjQyNE0tbElpTENyM050LXRROWtITFpSak1tVlBlZGszc0hFeXhlZlpWbElrNVQtdkw5b2JWbjdp?oc=5","date":"2022-12-09","type":"pipeline","source":"Healthcare Brew","summary":"Rite Aid faces a class-action lawsuit over its pharmacy benefits subsidiary - Healthcare Brew","headline":"Rite Aid faces a class-action lawsuit over its pharmacy benefits subsidiary","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}